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Cells progress from a normal to a cancerous state
by accumulating mutations. Recent mathematical
studies show how the size of the cellular population
in a local patch of tissue influences the spread of
cancer-promoting mutations.
Cancer results from mutations that alter the normal
regulation of cellular birth and death. Thus an impor-
tant aspect of cancer progression concerns the way in
which mutations accumulate in cellular lineages, an
issue discussed in an influential paper back in 1975 by
Cairns [1]. He noted that tissues such as the skin and
colon are divided into many small compartments,
such that there is little mixing of cellular populations
between adjacent compartments. Stem cells at the
base of each compartment renew the tissue, with
each stem cell division producing one stem cell and
one transit cell. The stem cell remains at the base of
the compartment and continues to renew the tissue.
The transit cell divides a limited number of times, pro-
ducing cells that move up from the basal layer and
eventually slough off from the surface.
Mutations that occur in the stem lineage remain in
the compartment and increase the risk of future
cancer. By contrast, mutations in the transit lineage
get ‘washed out’ as they move up the compartment
and slough off at the surface. Thus, the tissue archi-
tecture clears transit lineage mutations but retains
stem lineage mutations. Compartmentalizing tissue
also provides defense against aggressive cell lines by
physically partitioning the tissue into small units. In
order to be successful, a cancer line must obtain
mutations that allow invasion of neighboring compart-
ments and promote the spread of the cancer.
Cairns’ paper has been widely cited over the past
28 years. But few have expanded these fundamental
insights about how tissue architecture and the pattern
of cellular lineages affect the rate at which cancerous
mutations can accumulate. These quantitative issues
call for mathematical analysis [2]. Recently, Martin
Nowak and his colleagues have initiated a series of
mathematical studies on the accumulation of somatic
mutations and progression to cancer [3–5]. A new
paper from this group [6] published in this issue of
Current Biology considers how the size of the cellular
population in a compartment affects the success of
different kinds of mutations.
Cancer-promoting mutations often fall into one 
of two classes [7,8] (Figure 1). Gatekeeper muta-
tions abrogate checks and balances on cell division
and cell death, often leading to increased rates 
of cellular proliferation. Caretaker mutations enhance
genetic instability by increasing the rate of mutation
or chromosomal rearrangement. Michor et al. [6] note
that gatekeeper mutations have a selective advan-
tage because the cells carrying these mutations
replicate faster than their neighbors. By contrast,
caretaker mutations are probably disadvantageous
when they first arise because most mutations gener-
ated by genetic instability will decrease the success
of the cell. Genetic instability may eventually lead 
to a breakdown in gatekeeper functions, but the
issue here concerns the success of the initial care-
taker mutations.
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Figure 1. Two major classes of mutation in cancer progression.
(A) Gatekeeper mutations increase the rate of cellular prolifera-
tion. This may occur following mutations of oncogenes that
directly accelerate progress through the cell cycle. For
example, Myc is an oncogenic transcription factor that influ-
ences the gene expression of many other genes [11]. A recent
study suggests that Myc-activated genes gear cell physiology
to the rapid utilization of carbon sources and the expansion of
cellular mass [12]. Tumor suppressor genes are also gatekeep-
ers that increase proliferation by abrogating blocks to progres-
sion through the cell cycle. The retinoblastoma gene encodes
a tumor suppressor that acts as a transcription factor to control
many genes involved in cell proliferation [13]. The retinoblas-
toma transcription factor can, for example, silence target genes
of its binding partner E2F that play a key role in the DNA syn-
thesis (S) phase of the cell cycle. Michor et al.’s study [6] shows
that small cellular compartments best control gatekeeper muta-
tions. (B) Caretaker mutations cause genetic instability, increas-
ing the rate of cellular mutations. p53 is a caretaker and also
the most commonly mutated gene in human cancers [14]. p53
appears to be a transcription factor that regulates a variety of
other genes involved in cellular growth [15,16]. Among its func-
tions, p53 blocks progression through the cell cycle in
response to DNA damage. Loss of p53 therefore increases the
accumulation of mutations. It could be that bypassing DNA
repair both increases mutation and increases cellular prolifera-
tion, but Michor et al. [6] reasonably assume that genetic insta-
bility usually causes enough damage to reduce the average
rate of cellular proliferation. This group goes on to show that
large cellular compartments best control caretaker mutations.
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The contrast between advantageous gatekeeper
and deleterious caretaker mutations leads to the first
question. How does the size of a local cell population
influence the probability that gatekeeper and caretaker
mutations can spread and thus begin the progression
toward cancer? The main insight arises simply from
asking the question in this way, as this allows the pow-
erful theory of population genetics to be brought to
bear. In a large population, caretaker mutations with
increased rates of proliferation almost always succeed,
whereas gatekeeper mutations with decreased rates of
proliferation almost never succeed. Put another way,
natural selection among cell lineages deterministically
takes its course in a large population. In small popula-
tions, chance events can influence which cell lineages
succeed or fail. Thus, small populations increase the
probability that deleterious caretaker mutations spread
and decrease the probability that advantageous (to the
cell) gatekeeper mutations spread.
In terms of cancer risk, large populations lead to
cancer progression via initial gatekeeper mutations
and rapid cellular proliferation. By contrast, small pop-
ulations may often begin cancer progression with
caretaker mutations and genetic instability. This leads
to the second question addressed by Michor et al. —
what population size minimizes the risk of cancer?
This group developed a sophisticated mathematical
theory to study rates of cancer progression in differ-
ent cellular population sizes. They considered the path
to cancer via knockout of a tumor suppressor (TSP)
gene, a type of gatekeeper that when inactivated
causes the cell to proliferate more rapidly [9]. TSP
knockout can happen by two independent mutations
to the locus, at the usual mutation rate for normal cells
(Figure 2A). Alternatively, the cell can acquire one
standard mutation to TSP and a mutation to a care-
taker gene that raises the rate of chromosomal abnor-
malities (Figure 2B). A common feature of chromo
somal instability is loss of one chromosome of a pair
followed by duplication of the remaining chromosome.
This loss-duplication can cause a TSP locus that is
heterozygous for a knockout mutation to become
homozygous for the knockout [10]. Cells with chro-
mosomal instability undergo loss of heterozygosity at
a relatively high rate compared with normal somatic
mutations. So the rate-limiting pathway for knockout
of TSP would be one mutation causing chromosomal
instability and one mutation causing heterozygosity to
TSP, followed by rapid loss of heterozygosity [3].
I have mentioned many parameters: mutation rates
to TSP and caretaker genes, rate of loss of heterozy-
gosity, the growth advantage for TSP knockout cells,
the growth disadvantage for cells with caretaker
mutations, and the size of the local population of
cells. From these parameters one needs to analyze
the rates at which new mutations of different kinds
occur and become fixed in the local population of
cells. Remarkably, Michor et al. [6] were able to solve
these complicated rate problems with explicit equa-
tions. The solutions for the rate equations allowed
this group to show how cellular population size
affects cancer progression. Small populations are
Dispatch
R262
Figure 2. Two pathways to initiate cancer
progression.
(A) The first tumor suppressor mutation is
recessive and has no phenotypic effect.
The second mutation increases the rate of
cellular proliferation. Rapid cell proliferation
is best controlled by small compartments,
because chance events in small compart-
ments may cause the disappearance of the
second mutation before it can spread. 
(B) Two independent events begin the
process and may occur in either order. On
the left, the first tumor suppressor mutation
arises, followed by a mutation to a care-
taker gene. On the right, a caretaker muta-
tion occurs, followed by the first tumor
suppressor mutation. In either case, a care-
taker mutation causes greater genetic
instability. Genetic instability reduces cellu-
lar success, thus large compartments
provide the best control, because they
reduce chance events that can allow a
caretaker mutation to spread in spite of its
disadvantage in growth. Once both genetic
instability and the heterozygous TSP gene
become established, chromosomal aberra-
tions and loss of heterozygosity cause rel-
atively rapid progression to an inactivated
TSP locus. An inactivated TSP gene
increases cellular proliferation — thus, its
spread is best controlled by a small com-
partment. The opposing pressures on com-
partment size in the presence of genetic
instability suggest that intermediate com-
partment size is best at controlling this
route to cancer progression.
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best for controlling knockouts of TSP but are sus-
ceptible to the spread of genetic instability mutations.
Thus, for most parameters, intermediate population
sizes are favored to balance stochastic increase of
deleterious caretaker mutations and deterministic
increase of advantageous gatekeeper mutations. At
the intermediate population size that best controls
cancer, Michor et al. [6] calculated the relative contri-
bution of the two pathways to cancer. Recall that one
pathway follows two mutations to TSP at the normal
somatic rate. The other pathway follows one mutation
to cause genetic instability and one mutation to TSP,
followed by rapid loss of the second TSP allele via
chromosomal loss of heterozygosity. At the optimum
population size, a substantial fraction of cancer risk
comes via the pathway of early genetic instability fol-
lowed by loss of heterozygosity. This supports other
mathematical work by the same group showing that
genetic instability can be an important early step in
cancer progression [3–5].
Continuously dividing epithelial tissues such as the
skin and colon are separated into many small com-
partments [1]. Each compartment forms an isolated
local population in which the dynamics of early cancer
progression play out independently. According to
Michor et al. [6], small epithelial compartments protect
against the deterministic spread of gatekeeper knock-
outs but raise the risk of starting cancer progression
from caretaker mutations and genetic instability. This
newly developing quantitative theory may also help to
explain why different tissues progress toward cancer
in different ways [8]. For example, different tissues will
no doubt vary in the size of their cellular compart-
ments. Michor et al.’s analysis predicts that the small-
compartment epithelial tissues more often begin
cancer progression via genetic instability than do
tissues with larger compartments.
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